Tse joins Mary Babb Randolph Cancer Center

Will co-lead blood and marrow transplantation program

MORGANTOWN, W.Va. – William Tse, M.D., has joined the Mary Babb Randolph Cancer Center at West Virginia University as the co-leader of the Osborn Hematopoietic Malignancy and Transplantation Program, the state’s only source for blood and marrow transplants. Dr.  Tse treats patients with acute and chronic leukemia; lymphomas, including Hodgkin’s disease; multiple myeloma and other blood cancers.

His research interests include development of new treatments for various hematologic malignancies, especially for older patients.

William Tse, M.D.

After earning his medical degree and completing his residency and internship in China, Tse also received training in clinical pathology at North Shore University Hospital, NYU School of Medicine; internal medicine at Long Island Jewish Medical Center, Albert Einstein College of Medicine; and medical oncology at Fred Hutchinson Cancer Research Center/University of Washington School of Medicine. Before joining the staff at WVU, Tse was associate professor of medicine and pediatrics in the Division of Medical Oncology at the University of Colorado Denver Cancer Center.

Tse is board certified in internal medicine and medical oncology. He serves on the editorial board of the Journal of Hematology/Oncology.


For more information:
Amy Johns, HSC News Service, 304-293-7087
md: 10-23-09

Return To News Releases